Literature DB >> 2140261

Essential contribution of macrophages to islet cell destruction in vivo and in vitro.

H Kolb1, V Burkart, B Appels, H Hanenberg, G Kantwerk-Funke, U Kiesel, J Funda, U Schraermeyer, V Kolb-Bachofen.   

Abstract

A number of observations indicate an essential role of macrophage activity in the development of hyperglycemia in animal models of Type I diabetes. Administration of macrophage-toxic silica particles prevents spontaneous diabetes development in BB rats or NOD mice. The same result was noted in the low-dose streptozotocin-induced diabetes model in mice. Macrophages appear to be the first immune cells infiltrating islets during early insulitis. Macrophages in inflamed islets of BB rats bear the ED1 marker, whereas resident islet macrophages are ED2-positive. In vitro, ED1-positive macrophages were found to lyse pancreatic islet cells to a similar degree to various tumor cells but not normal thyrocytes. Macrophage-mediated lysis of islet cells was inhibited in the presence of 10-100 mM nicotinamide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140261     DOI: 10.1016/s0896-8411(09)90020-8

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  17 in total

Review 1.  Type 1 (insulin-dependent) diabetes mellitus and nitric oxide.

Authors:  H Kolb; V Kolb-Bachofen
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 3.  Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.

Authors:  David L Morris
Journal:  Mol Endocrinol       Date:  2015-05-22

4.  When beta cells talk back.

Authors:  Heather C Denroche; Dominika Nackiewicz; C Bruce Verchere
Journal:  Diabetologia       Date:  2017-09-20       Impact factor: 10.122

5.  Protection of islet cells from inflammatory cell death in vitro.

Authors:  V Burkart; H Kolb
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Imaging NF-κB activity in a murine model of early stage diabetes.

Authors:  Toloo Taghian; Valeriy G Metelev; Surong Zhang; Alexei A Bogdanov
Journal:  FASEB J       Date:  2019-11-29       Impact factor: 5.191

7.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro.

Authors:  V Burkart; T Koike; H H Brenner; H Kolb
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

9.  Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms.

Authors:  Qian Liu; Krishnan Sundar; Pankaj K Mishra; Gity Mousavi; Zhugong Liu; Andrew Gaydo; Farhang Alem; David Lagunoff; David Bleich; William C Gause
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

10.  Effect of nicotinamide on early graft failure following intraportal islet transplantation.

Authors:  Da-Yeon Jung; Jae Berm Park; Sung-Yeon Joo; Jae-Won Joh; Choon-Hyuck Kwon; Ghee-Young Kwon; Sung-Joo Kim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.